Skip to main content
. 2020 Jul 17;20:666. doi: 10.1186/s12885-020-07147-y

Table 2.

Five and 10-year lung cancer related, other cancer related and non-cancer related death probability

Characteristics Lung cancer related death probability Other cancer related death probability Non-cancer related death probability
5 Year 10 Year P 5 Year 10 Year P 5 Year 10 Year P
(%) (%) (%) (%) (%) (%)
Diagnostic Age, years < 0.001 0.159 < 0.001
 < 45 28.1 36.9 0.4 0.4 4.5 8.2
 45–64 31.7 39.6 1.4 1.6 7.3 14.2
 65–74 33.6 41.4 1.2 1.9 12.3 23.3
 ≥ 75 37.0 44.3 1.4 1.7 19.6 34.2
Gender < 0.001 0.146 < 0.001
 Female 29.9 38.7 1.2 1.7 9.8 19.3
 Male 37.3 44.1 1.4 1.7 14.2 24.9
Ethnicity < 0.001 < 0.001 < 0.001
 White 33.8 41.5 1.3 1.7 12.4 22.7
 Asian 31.2 41.4 0.8 1.2 8.5 16.1
 Black 34.2 40.8 2.0 2.2 10.8 20.4
 Others/Unknown 23.7 24.8 0.3 0.3 9.8 36.1
Primary tumor location 0.09 0.676 0.097
 Left-sided 34.1 41.9 1.3 1.7 12.2 23.2
 Right-sided 33.3 41.0 1.3 1.7 11.9 21.4
Anatomic sites < 0.001 0.45 0.032
 Upper 31.9 39.2 1.3 1.7 12.0 23.1
 Middle 33.6 41.5 1.2 1.5 11.7 18.9
 Lower 35.2 44.0 1.2 1.7 12.4 21.4
 Bronchus/Others 47.3 53.2 1.7 1.9 10.8 16.6
Histologic subtype < 0.001 0.04 < 0.001
 ADC 33.4 42.2 1.3 1.7 10.3 19.6
 SCC 35.2 40.9 1.3 1.6 16.6 29.1
 BAC 23.8 33.8 0.8 1.5 8.4 16.2
 ADSC 41.7 48.7 1.6 1.7 12.7 21.8
 LCC 43.7 49.8 2.1 2.3 13.1 20.6
 Other 29.0 40.6 1.1 1.1 7.2 17.9
 Unspecified 41.4 45.6 1.9 2.2 11.3 20.1
Differentiation < 0.001 < 0.001 < 0.001
 Well 17.3 26.5 0.7 1.2 9.1 20.5
 Moderately 31.5 40.2 1.1 1.6 12.8 22.4
 Poorly 40.7 47.0 1.6 1.9 12.1 22.1
 Undifferentiated 41.3 47.8 1.9 2.1 12.8 21.2
Clinical stage < 0.001 < 0.001 < 0.001
 I 22.0 30.0 1.0 1.4 13.1 25.7
 II 46.5 53.1 1.5 1.9 11.8 18.7
 III 53.5 61.1 1.8 2.2 9.7 16.1
 IV 62.8 71.3 2.6 2.6 8.4 11.9
Tumor size, cm < 0.001 < 0.001 < 0.001
 ≤ 1.0 18.4 27.4 0.8 1.9 8.8 18.3
 1.1 to 3.0 26.2 34.5 1.1 1.6 12.3 23.8
 3.1 to 5.0 39.6 47.2 1.5 1.7 12.8 22.6
 5.1 to 7.0 47.6 53.8 1.5 1.9 11.0 17.9
 > 7.1 57.6 62.1 1.8 2.5 10.2 15.6
Tumor extent < 0.001 < 0.001 < 0.001
 Local 28.0 35.9 1.1 1.5 12.5 23.8
 Regional 60.3 65.9 2.0 2.7 13.1 16.9
 Distant 43.8 51.3 1.6 2.0 11.0 19.1
Lymph node stage < 0.001 < 0.001 < 0.001
 N0 25.2 33.2 1.1 1.5 12.9 25.0
 N1 49.6 56.7 1.5 2.0 10.9 16.6
 N2/N3 59.0 66.3 1.9 2.2 8.8 14.0
Examined lymph node < 0.001 0.379 < 0.001
 < 5 34.5 42.7 1.5 1.9 13.2 24.7
 5 to 9 32.5 40.1 1.1 1.6 12.0 22.0
 10 to 14 32.8 40.2 1.2 1.6 11.5 21.8
 15 to 20 34.0 42.1 1.3 1.5 10.5 18.7
 ≥ 20 36.2 43.0 1.4 1.7 11.4 18.3
Positive lymph node < 0.001 < 0.001 < 0.001
 0 25.7 33.5 1.1 1.5 12.8 24.9
 1 49.6 56.8 1.9 2.4 10.5 17.0
 2 52.3 59.9 1.6 1.7 10.2 15.3
 3 55.6 63.7 1.4 2.0 10.4 14.9
 ≥ 4 63.7 70.9 1.8 1.9 8.8 11.4
Type of surgery < 0.001 0.249 < 0.001
 Lobectomy 32.0 39.7 1.2 1.7 11.8 22.0
 Pneumonectomy 51.0 57.6 1.7 1.8 11.5 17.4
 Sub-lobar 35.7 43.9 1.3 1.8 14.4 26.7
Chemotherapy < 0.001 0.214 < 0.001
 None 28.2 35.5 1.2 1.7 14.0 26.1
 Yes 46.4 54.9 1.4 1.8 7.3 13.0
Radiotherapy < 0.001 < 0.001 < 0.001
 None 30.0 37.7 1.2 1.6 12.5 23.3
 Yes 56.9 64.3 1.9 2.1 8.8 14.8